General Cannabis Corp Stock Return On Equity
CANN Stock | USD 0.08 0.0002 0.25% |
General Cannabis Corp fundamentals help investors to digest information that contributes to General Cannabis' financial success or failures. It also enables traders to predict the movement of General OTC Stock. The fundamental analysis module provides a way to measure General Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to General Cannabis otc stock.
General |
General Cannabis Corp OTC Stock Return On Equity Analysis
General Cannabis' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current General Cannabis Return On Equity | -0.73 |
Most of General Cannabis' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, General Cannabis Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition |
Based on the latest financial disclosure, General Cannabis Corp has a Return On Equity of -0.7306. This is 96.95% lower than that of the Commercial Services & Supplies sector and significantly lower than that of the Industrials industry. The return on equity for all United States stocks is 135.68% higher than that of the company.
General Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses General Cannabis' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of General Cannabis could also be used in its relative valuation, which is a method of valuing General Cannabis by comparing valuation metrics of similar companies.General Cannabis is currently under evaluation in return on equity category among related companies.
General Fundamentals
Return On Equity | -0.73 | |||
Return On Asset | -0.0299 | |||
Profit Margin | (0.59) % | |||
Operating Margin | (0.09) % | |||
Current Valuation | 35.32 M | |||
Shares Outstanding | 114.17 M | |||
Shares Owned By Insiders | 82.81 % | |||
Price To Earning | (0.58) X | |||
Price To Book | 2.67 X | |||
Price To Sales | 1.23 X | |||
Revenue | 5.93 M | |||
Gross Profit | 1.49 M | |||
EBITDA | (6.6 M) | |||
Net Income | (8.87 M) | |||
Cash And Equivalents | 1.07 M | |||
Cash Per Share | 0.01 X | |||
Total Debt | 5.91 M | |||
Debt To Equity | 0.99 % | |||
Current Ratio | 0.61 X | |||
Book Value Per Share | 0.08 X | |||
Cash Flow From Operations | (2.65 M) | |||
Earnings Per Share | (0.09) X | |||
Number Of Employees | 77 | |||
Beta | 1.09 | |||
Market Capitalization | 18.61 M | |||
Total Asset | 22.02 M | |||
Retained Earnings | (33.4 M) | |||
Working Capital | (16.51 M) | |||
Current Asset | 1.42 M | |||
Current Liabilities | 17.93 M | |||
Z Score | 0.4 | |||
Net Asset | 22.02 M |
About General Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze General Cannabis Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of General Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of General Cannabis Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards General Cannabis in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, General Cannabis' short interest history, or implied volatility extrapolated from General Cannabis options trading.
Pair Trading with General Cannabis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if General Cannabis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in General Cannabis will appreciate offsetting losses from the drop in the long position's value.Moving against General OTC Stock
0.43 | ELGL | Element Global | PairCorr |
The ability to find closely correlated positions to General Cannabis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace General Cannabis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back General Cannabis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling General Cannabis Corp to buy it.
The correlation of General Cannabis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as General Cannabis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if General Cannabis Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for General Cannabis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in General Cannabis Corp. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for General OTC Stock analysis
When running General Cannabis' price analysis, check to measure General Cannabis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy General Cannabis is operating at the current time. Most of General Cannabis' value examination focuses on studying past and present price action to predict the probability of General Cannabis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move General Cannabis' price. Additionally, you may evaluate how the addition of General Cannabis to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |